Clinical Trials Browser

TAS 102 × regorafenib × Gastrointestinal × Clear all

NCT05993702 2023-08-15

TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer

Gastrointestinal

TAS 102